|
|
||||||||
Address correspondence to John P. Ofenstein, Ph.D., Clinical Pharmacology and Toxicology Laboratory, Childrens Hospital of Michigan/Wayne State University School of Medicine, 3901 Beaubien Boulevard, Detroit, MI 48201, USA; tel 313 745 5873; fax 313 745 5441; e-mail john.ofenstein{at}wayne.edu.
Group B Streptococcus (GBS) infection leading to sepsis and lung injury is a major cause of neonatal morbidity and mortality. Lung injury may result from overproduction of pro-inflammatory mediators (cytokines), caused by nitric oxide (NO). Our objective was to characterize the molecular signaling events involving the pro-inflammatory mediators interleukin-6 (IL-6) and macrophage inflammatory protein (MIP-2) in the presence of aminoguanidine (AG), an inducible nitric oxide synthase (iNOS) specific inhibitor, in lung tissue from GBS-treated young rats. Changes in iNOS mRNA, lactic acid, and rectal temperature were determined as markers of the inflammatory response. Expression and regulation of IL-6 and MIP-2 mRNA in lung tissue were studied by RT-PCR with densitometry analysis. GBS treatment of young rats induced the expression of pro-inflammatory mediators IL-6 (6-fold) and MIP-2 (3-fold) in lung tissue compared to controls. AG decreased IL-6 and MIP-2 expression. Addition of L-arginine (L-arg) reversed the AG effect on IL-6 and MIP-2 expression. These data suggest a role for the nitric oxide pathway in the overproduction of pro-inflammatory mediators IL-6 and MIP-2 during GBS-induced lung inflammation. This pathway may be responsible for the initiation of lung injury.
Keywords: Group B streptococcus, neonatal sepsis, lung injury, aminoguanidine, arginine, interleukin-6, macrophage inflammatory protein
This article has been cited by other articles:
![]() |
G. Natarajan, M. Glibetic, V. Raykova, J. P Ofenstein, R. L Thomas, and J. V Aranda Nitric Oxide and Prostaglandin Response to Group B Streptococcal Infection in the Lung Ann. Clin. Lab. Sci., January 1, 2007; 37(2): 170 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Farley, L. F. Wang, H. M. Razavi, C. Law, M. Rohan, D. G. McCormack, and S. Mehta Effects of macrophage inducible nitric oxide synthase in murine septic lung injury Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1164 - L1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Puliti, C. von Hunolstein, F. Bistoni, G. Orefici, and L. Tissi Inhibition of Nitric Oxide Synthase Exacerbates Group B Streptococcus Sepsis and Arthritis in Mice Infect. Immun., August 1, 2004; 72(8): 4891 - 4894. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hongo, J. S. Bryson, A. M. Kaplan, and D. A. Cohen Endogenous Nitric Oxide Protects against T Cell-Dependent Lethality during Graft-versus-Host Disease and Idiopathic Pneumonia Syndrome J. Immunol., August 1, 2004; 173(3): 1744 - 1756. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |